Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma
Clinical trial NCT03476174 · TERMINATED
Trial details
- NCT number
- NCT03476174
- Sponsor
- Ralph Hauke
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2019-10-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.